Carregant...
Development of mobile technologies for the prevention of cervical cancer in Santiago, Chile study protocol: a randomized controlled trial
BACKGROUND: In Chile, more than 500 women die every year from cervical cancer, and a majority of Chilean women are not up-to-date with their Papanicolau (Pap) test. Mobile health has great potential in many health areas, particularly in health promotion and prevention. There are no randomized contro...
Guardat en:
| Publicat a: | BMC Cancer |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5729241/ https://ncbi.nlm.nih.gov/pubmed/29237420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3870-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|